This trial is looking at whether bariatric surgery can help improve nonalcoholic fatty liver disease (NAFLD) by measuring the liver's ability to burn fat and make glucose.
1 Primary · 1 Secondary · Reporting Duration: 12 months
Experimental Treatment
18 Total Participants · 1 Treatment Group
Primary Treatment: Vertical Sleeve Gastrectomy (VSG) · No Placebo Group · N/A
Age 40 - 67 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Texas | 25.0% |
Georgia | 25.0% |
Minnesota | 25.0% |
Other | 25.0% |
18 - 65 | 100.0% |
University of Minnesota | 100.0% |
Met criteria | 100.0% |